The optimal degree of core temperature for hypothermic circulatory arrest in complex aortic arch surgery: results from 1310 patients
European Journal of Cardio-Thoracic Surgery · 2024
DOI: 10.1093/ejcts/ezae311 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cardio-Thoracic Surgery, 2024. Verfasst von Kai Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Surgery, Fuwai Hospital, National Center for Cardiovascular Diseases, National Clinical Research Center for Cardiovascular Dis…. Hauptthemen laut MEDLINE: Aorta, Thoracic, Aortic Dissection. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: National High Level Hospital Clinical Research Funding, Beijing Municipal Natural Science Foundation.
Abstract (Originalsprache)
OBJECTIVES The optimal core temperature for hypothermic circulatory arrest during aortic arch surgery remains contentious. This study aims to evaluate patient outcomes under various temperatures within a large single-centre cohort. METHODS Between 2010 and 2018, patients diagnosed with type A aortic dissection underwent total arch replacement at Fuwai Hospital were enrolled. They were categorized into 4 groups: deep hypothermia group, low-moderate hypothermia group, high-moderate hypothermia group and mild hypothermia group. Clinical data were analysed to ascertain differences between the groups. RESULTS A total of 1310 patients were included in this cohort. Operative mortality stood at 6.9% (90/1310), with a higher incidence observed in the deep hypothermia group [29 (12.9%); 35 (6.9%); 21 (4.8%); 5 (3.4%); all adjusted P < 0.05]. Overall 10-year survival was 80.3%. Long-term outcomes did not significantly differ among the groups. Multivariable logistic analysis revealed a protective effect of higher core temperature on operative mortality (odds ratio 0.848, 95% confidence interval 0.766–0.939; P = 0.001). High-moderate hypothermia emerged as an independent protective factor for operative mortality (odds ratio 0.303, 95% confidence interval 0.126–0.727; P = 0.007). Multivariable Cox analysis did not detect an effect of hypothermic circulatory arrest on long-term survival (all P > 0.05). CONCLUSIONS High-moderate hypothermia (24.1–28°C) offers the most effective protection against surgical mortality and is therefore recommended. Different hypothermic circulatory arrest temperatures do not influence long-term survival or quality of life.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Vascular Surgery, Fuwai Hospital, National Center for Cardiovascular Diseases, National Clinical Research Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical Co…
- Department of Surgical Intensive Care Unit, National Center for Cardiovascular Diseases, National Clinical Research Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical Colleg…
Förderung
- National High Level Hospital Clinical Research Funding
- Beijing Municipal Natural Science Foundation
Zitieren
APA
Zhang, K., Zhou, C., Gao, S., Ji, Y., Qiu, J., Cao, F., Qiu, J., & Yu, C. (2024). The optimal degree of core temperature for hypothermic circulatory arrest in complex aortic arch surgery: results from 1310 patients. European Journal of Cardio-Thoracic Surgery. https://doi.org/10.1093/ejcts/ezae311
Vancouver
Zhang K, Zhou C, Gao S, Ji Y, Qiu J, Cao F, et al. The optimal degree of core temperature for hypothermic circulatory arrest in complex aortic arch surgery: results from 1310 patients. European Journal of Cardio-Thoracic Surgery. 2024. doi:10.1093/ejcts/ezae311
BibTeX
@article{Zhang2024,
author = {Zhang, Kai and Zhou, Chenyu and Gao, Shiqi and Ji, Yumeng and Qiu, Jiawei and Cao, Fangfang and Qiu, Juntao and Yu, Cuntao},
title = {The optimal degree of core temperature for hypothermic circulatory arrest in complex aortic arch surgery: results from 1310 patients},
journal = {European Journal of Cardio-Thoracic Surgery},
year = {2024},
doi = {10.1093/ejcts/ezae311}
}
EUVIMED